Back to News
Mergers & Acquisitions

Drinks With The Deal: Gibson Dunn's Muzumdar on Direct Lending, M&A in Tough Times

|
Published: November 10th, 2022
Saee Muzumdar, an M&A partner at Gibson Dunn in New York, discusses what she learned from beginning her career during the financial crisis of 2008 and how dealmakers are adjusting to challenging markets.

As financing markets have become more challenging, borrowers have adjusted by becoming more creative in arranging financing for their deals, Saee Muzumdar, an M&A partner at Gibson, Dunn & Crutcher LLP, said on this week’s Drinks With The Deal podcast.

As an example, Muzumdar pointed to a deal in which funds affiliated with Blackstone Inc. (BX) agreed to take a 55% stake in the climate technologies unit of Emerson Electric Co. (EMR). Blackstone is financing the deal in part with funds from a consortium of direct lenders. Muzumdar noted that the deal reflects an expansion in the kinds of transactions direct lenders can fund as well as the ability to form a syndicate of direct lenders rather than relying on a single one to provide the debt for a buyout.

“There is an expansion of what the direct lenders can and are willing to do,” said Muzumdar, who did not work on the deal.

Muzumdar started her career at Gibson Dunn in fall 2008, when the financial crisis made for an exceptionally challenging M&A market. As a result, she said, she worked on a range of transactions from financings to bankruptcies and became a more well-rounded lawyer.

Here’s the podcast with Saee Muzumdar:

More podcasts from The Deal are available on iTunesSpotify and on TheDeal.com.

More From Mergers & Acquisitions

Mergers & Acquisitions

Dow Considers Options for Infrastructure Assets

By Tom Terrarosa
|
Published: December 6th, 2023
The company is working with two bulge-bracket advisers to build a potential sale process around Gulf Coast infrastructure that sources said could amount to around $5 billion.
Mergers & Acquisitions

Resetting Expectations for IFF's Pharma Exit

By Tom Terrarosa
|
Published: December 5th, 2023
The chemicals conglomerate is said to need a deal for its pharma business, but the market may deliver it a disappointment on valuation.
Mergers & Acquisitions

Talking M&A: Competition Complexities

By The Deal Contributors
|
Published: November 20th, 2023
Following a number of crackdowns from global competition regulators, Baker McKenzie partners Duffy Lorenz and Creighton Macy share their experiences, insights and advice for clients looking to run a smooth deal process and minimize unexpected antitrust curveballs.